Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study

NCT00240279 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00240279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00240279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
October 31, 2008
Enrollment
10
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia